1. Home
  2. GCTK vs ATCH Comparison

GCTK vs ATCH Comparison

Compare GCTK & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • ATCH
  • Stock Information
  • Founded
  • GCTK 2001
  • ATCH 2022
  • Country
  • GCTK United States
  • ATCH United States
  • Employees
  • GCTK N/A
  • ATCH N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • ATCH
  • Sector
  • GCTK Health Care
  • ATCH
  • Exchange
  • GCTK Nasdaq
  • ATCH Nasdaq
  • Market Cap
  • GCTK 3.3M
  • ATCH 2.9M
  • IPO Year
  • GCTK N/A
  • ATCH N/A
  • Fundamental
  • Price
  • GCTK $10.59
  • ATCH $0.39
  • Analyst Decision
  • GCTK
  • ATCH
  • Analyst Count
  • GCTK 0
  • ATCH 0
  • Target Price
  • GCTK N/A
  • ATCH N/A
  • AVG Volume (30 Days)
  • GCTK 4.0M
  • ATCH 20.1M
  • Earning Date
  • GCTK 08-14-2025
  • ATCH 09-05-2025
  • Dividend Yield
  • GCTK N/A
  • ATCH N/A
  • EPS Growth
  • GCTK N/A
  • ATCH N/A
  • EPS
  • GCTK N/A
  • ATCH N/A
  • Revenue
  • GCTK N/A
  • ATCH $14,825,966.00
  • Revenue This Year
  • GCTK N/A
  • ATCH N/A
  • Revenue Next Year
  • GCTK N/A
  • ATCH N/A
  • P/E Ratio
  • GCTK N/A
  • ATCH N/A
  • Revenue Growth
  • GCTK N/A
  • ATCH 1066.77
  • 52 Week Low
  • GCTK $4.22
  • ATCH $0.14
  • 52 Week High
  • GCTK $3,756.00
  • ATCH $26.94
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 79.88
  • ATCH 76.54
  • Support Level
  • GCTK $4.33
  • ATCH $0.17
  • Resistance Level
  • GCTK $5.88
  • ATCH $0.24
  • Average True Range (ATR)
  • GCTK 0.88
  • ATCH 0.03
  • MACD
  • GCTK 0.42
  • ATCH 0.02
  • Stochastic Oscillator
  • GCTK 64.21
  • ATCH 87.28

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: